Long-Term Outcomes After Reirradiation With Spine Stereotactic Body Radiation Therapy: Single-Institutional Retrospective Experience
Practical Radiation Oncology · 2025
DOI: 10.1016/j.prro.2025.08.006 ↗Kurz gefasst
Fachartikel in der Zeitschrift Practical Radiation Oncology, 2025. Verfasst von J John Lucido und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Mayo Clinic, Rochester, Minnesota. Electronic address: lucido.joseph@mayo.edu. Hauptthemen laut MEDLINE: Radiosurgery, Spinal Neoplasms, Re-Irradiation. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Reirradiation of spinal metastases using stereotactic body radiation therapy (SBRT) presents clinical challenges, with limited patient outcomes data to guide decision-making. We report a retrospective, single-institutional experience of 107 lesions treated in 91 patients. Of these, 88 (72%) lesions were initially irradiated with conventional radiation therapy (median equivalent dose of 33 Gy to the target, IQR, 23-35 Gy) with a median time to reirradiation of 12 months (IQR, 4-21 months). For reirradiation, most lesions received either 1 fraction (18-24 Gy) or 3 fractions (30-36 Gy) of SBRT. The median equivalent dose in 2 Gy fractions was 38 Gy (IQR, 30-41 Gy), 27 Gy (22-36 Gy), and 65 (54-73 Gy) for previous courses, reirradiation, and cumulatively, respectively. At 1 year, overall survival was 61% with a cumulative incidence of local failure at 12% and vertebral compression fracture at 9% considering death as a competing risk. None of the 79 treated lesions at L1 or above developed radiation myelitis, but 5 patients developed chronic peripheral neuropathy. In our analysis, most adverse events or local failures occur within the 2 years after retreatment. These findings demonstrate the safety and effectiveness of spine reirradiation with SBRT.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Radiation Oncology, Mayo Clinic, Rochester, Minnesota. Electronic address: lucido.joseph@mayo.edu.
- Department of Radiation Oncology, Duke University, Durham, North Carolina.
- Department of Clinical Trials and Biostatistics, Mayo Clinic, Rochester, Minnesota.
- Department of Radiology, Mayo Clinic, Rochester, Minnesota.
- Department of Orthopedic Surgery, Mayo Clinic, Rochester, Minnesota.
- Department of Oncology, Mayo Clinic, Rochester, Minnesota.
Zitieren
APA
Lucido, J. J., Mullikin, T. C., Harmsen, W. S., Pulsipher, S. D., Johnson-Tesch, B. A., Morris, J. M., Rose, P. S., Siontis, B. L., Brinkmann, D. H., Owen, D., Park, S. S., Rajkumar, A. W., Kowalchuk, R. O., & Merrell, K. W. (2025). Long-Term Outcomes After Reirradiation With Spine Stereotactic Body Radiation Therapy: Single-Institutional Retrospective Experience. Practical Radiation Oncology. https://doi.org/10.1016/j.prro.2025.08.006
Vancouver
Lucido JJ, Mullikin TC, Harmsen WS, Pulsipher SD, Johnson-Tesch BA, Morris JM, et al. Long-Term Outcomes After Reirradiation With Spine Stereotactic Body Radiation Therapy: Single-Institutional Retrospective Experience. Practical Radiation Oncology. 2025. doi:10.1016/j.prro.2025.08.006
BibTeX
@article{Lucido2025,
author = {Lucido, J John and Mullikin, Trey C and Harmsen, W Scott and Pulsipher, Sydney D and Johnson-Tesch, Benjamin A and Morris, Jonathan M and Rose, Peter S and Siontis, Brittany L and Brinkmann, Debra H and Owen, Dawn and Park, Sean S and Rajkumar, Anne W and Kowalchuk, Roman O and Merrell, Kenneth W},
title = {Long-Term Outcomes After Reirradiation With Spine Stereotactic Body Radiation Therapy: Single-Institutional Retrospective Experience},
journal = {Practical Radiation Oncology},
year = {2025},
doi = {10.1016/j.prro.2025.08.006}
}
EUVIMED